Talat Imran - 21 Mar 2024 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Executive Officer, Director
Signature
Talat Imran
Issuer symbol
RANI
Transactions as of
21 Mar 2024
Transactions value $
$0
Form type
4
Filing time
22 Mar 2024, 21:00:10 UTC
Previous filing
19 Dec 2023
Next filing
10 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +1,085,000 $0 1,085,000 21 Mar 2024 Class A Common Stock 1,085,000 $3.6 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.